H. -P. Lohrmann
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 7
- Blood groups and transfusion 4
- Acute Myeloid Leukemia Research 2
- Biochemistry top 10%
- Blood transfusion and management 2
-
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 3
-
- Blood disorders and treatments 3
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- RH HerzigRA YankeeGP HerzigW. SchremlPeter WernetH. HeimpelHans‐Joachim WilkeWolfgang Hiddemann
- Cited by
- HematologyBiochemistryOncology
- Partner nations
- GermanyUnited States
In The Last Decade
H. -P. Lohrmann
22 papers receiving 245 citations
Peers
Comparison fields: 5 of 60
- Hematology 173
- Biochemistry 57
- Oncology 106
- Genetics 27
- Management of Technology and Innovation 16
Countries citing papers authored by H. -P. Lohrmann
This map shows the geographic impact of H. -P. Lohrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. -P. Lohrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. -P. Lohrmann more than expected).
Fields of papers citing papers by H. -P. Lohrmann
This network shows the impact of papers produced by H. -P. Lohrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. -P. Lohrmann. The network helps show where H. -P. Lohrmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. -P. Lohrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 8 | |
| 2 | 1995 | 19 | |
| 3 | Stem cell defects after cytoreductive therapy in man. | 1985 | 16 |
| 4 | 1984 | 26 | |
| 5 | 1982 | 7 | |
| 6 | [Effects of alcohol on hematopoiesis]. | 1981 | 1 |
| 7 | 1980 | 13 | |
| 8 | 1979 | 5 | |
| 9 | 1979 | 2 | |
| 10 | Thymidine-suicide of human granulocytic progenitor cells (CFU-C). | 1978 | 2 |
| 11 | 1978 | 1 | |
| 12 | 1978 | 8 | |
| 13 | 1978 | 2 | |
| 14 | Education of lymphocytes in vivo following a transient take of a matched unrelated bone-marrow graft in man. | 1977 | 1 |
| 15 | 1976 | 22 | |
| 16 | 1975 | 2 | |
| 17 | Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia. | 1974 | 28 |
| 18 | 1973 | 2 | |
| 19 | 1973 | 3 | |
| 20 | 1972 | 5 |
About H. -P. Lohrmann
H. -P. Lohrmann is a scholar working on Hematology, Transplantation, Biochemistry, Genetics and Oncology, having authored 23 papers that have together received 303 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (7 papers), Blood groups and transfusion (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Blood disorders and treatments (3 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers), Acute Myeloid Leukemia Research (2 papers) and Blood transfusion and management (2 papers). The work is most often cited by research in Hematology (173 citations), Biochemistry (57 citations), Oncology (106 citations), Genetics (27 citations) and Management of Technology and Innovation (16 citations). H. -P. Lohrmann has collaborated with scholars based in Germany and United States. Frequent co-authors include RH Herzig, RA Yankee, GP Herzig, W. Schreml, Peter Wernet, H. Heimpel, Hans‐Joachim Wilke, Wolfgang Hiddemann, Malcolm I. Bull and Ronald A. Yankee. Their work appears in journals such as Annals of Hematology, Blood, The Lancet, Oncology and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.